Pages that link to "Item:Q2475730"
From MaRDI portal
The following pages link to The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials (Q2475730):
Displaying 17 items.
- An information-theoretic approach to surrogate-marker evaluation with failure time endpoints (Q746103) (← links)
- Choice of units of analysis and modeling strategies in multilevel hierarchical models (Q957034) (← links)
- Using earlier measures in a longitudinal sequence as a potential surrogate for a later one (Q962388) (← links)
- Flexible surrogate marker evaluation from several randomized clinical trials with continuous endpoints, using R and SAS (Q1020068) (← links)
- Center-within-trial versus trial-level evaluation of surrogate endpoints (Q1623614) (← links)
- Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials (Q1658329) (← links)
- The evaluation of surrogate endpoints. (Q1773294) (← links)
- Statistical evaluation of surrogate endpoints with examples from cancer clinical trials (Q2792764) (← links)
- Comparing biomarkers as principal surrogate endpoints (Q2893405) (← links)
- Meta-analysis for surrogacy: accelerated failure time models and semicompeting risks modeling (Q2894010) (← links)
- Bayesian adaptive trial design for a newly validated surrogate endpoint (Q2894012) (← links)
- A simple meta-analytic approach for using a binary surrogate endpoint to predict the effect of intervention on true endpoint (Q3434121) (← links)
- Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints (Q3445296) (← links)
- On the relationship between the causal‐inference and meta‐analytic paradigms for the validation of surrogate endpoints (Q3465713) (← links)
- The validation of surrogate endpoints in meta-analyses of randomized experiments (Q4489920) (← links)
- True endpoint reduction by surrogate endpoints (Q4638854) (← links)
- Statistical Methods for Clinical Studies in the Presence of Surrogate End Points (Q4785433) (← links)
